We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$914M
AUM Growth
+$67.7M
(+8%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
292
New
16
Increased
25
Reduced
16
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$6.32M |
| 2 |
JPMorgan Chase
JPM
|
+$3.57M |
| 3 |
Pfizer
PFE
|
+$3.16M |
| 4 |
GSK
GSK
|
+$2.84M |
| 5 |
Nordson
NDSN
|
+$528K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLC
Clarcor
CLC
|
+$1.39M |
| 2 |
CLNY
Colony Capital, Inc.
CLNY
|
+$454K |
| 3 |
STJ
St Jude Medical
STJ
|
+$393K |
| 4 |
Idexx Laboratories
IDXX
|
+$389K |
| 5 |
Portland General Electric
POR
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.03% |
| 2 | Technology | 16.72% |
| 3 | Healthcare | 13.67% |
| 4 | Communication Services | 12.36% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
ASE Group
ASX
$107B
| $140K | 0.02% |
21,658
| – | – |
2016 Q1
4 quarters
|
|
|
FTR
277
DELISTED
Frontier Communications Corp.
FTR
| $139K | 0.02% |
4,331
| – | – |
2016 Q1
4 quarters
|
|
|
OTIC
278
DELISTED
Otonomy, Inc.
OTIC
| $124K | 0.01% |
10,112
| – | – |
2016 Q2
3 quarters
|
|
279
Ericsson
ERIC
$34.2B
| $109K | 0.01% |
16,420
| – | – |
2016 Q1
4 quarters
|
|
280
DELISTED
Great Lakes Dredge & Dock
GLDD
| $104K | 0.01% |
25,885
| – | – |
2016 Q1
4 quarters
|
|
281
Chimera Investment
CIM
$717M
| – | – |
-4,229
| Closed | -$216K | – |
|
282
Molina Healthcare
MOH
$11.1B
| – | – |
-5,481
| Closed | -$297K | – |
|
283
Philips
PHG
$25.3B
| – | – |
-14,185
| Closed | -$321K | – |
|
|
284
Portland General Electric
POR
$5.18B
| – | – |
-7,711
| Closed | -$334K | – |
|
285
Ryanair
RYAAY
$27.2B
| – | – |
-7,360
| Closed | -$245K | – |
|
286
Innovex International
INVX
$1.92B
| – | – |
-3,569
| Closed | -$214K | – |
|
|
ISBC
287
DELISTED
Investors Bancorp, Inc.
ISBC
| – | – |
-18,314
| Closed | -$255K | – |
|
|
CLC
288
DELISTED
Clarcor
CLC
| – | – |
-16,808
| Closed | -$1.39M | – |
|
289
DELISTED
Team Health Holdings Inc
TMH
| – | – |
-5,284
| Closed | -$230K | – |
|
|
CLNY
290
DELISTED
Colony Capital, Inc.
CLNY
| – | – |
-22,424
| Closed | -$454K | – |
|
|
STJ
291
DELISTED
St Jude Medical
STJ
| – | – |
-4,900
| Closed | -$393K | – |
|
|
AIRM
292
DELISTED
Air Methods Corp
AIRM
| – | – |
-8,656
| Closed | -$276K | – |
|
Similar funds
Henshaw Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Henshaw Capital held 292 positions worth $914M, up 8% from $847M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Henshaw Capital's Q1 2017 filing shows 16 new, 25 increased, 16 reduced and 12 closed positions. Its largest new stake was Nordson: 4,459 shares worth $548K. The largest sale was Clarcor, an estimated $1.39M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Henshaw Capital's largest Q1 2017 buy was Nordson: 4,459 shares worth $548K.
- Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q1 2017, an estimated $6.32M increase.
- Henshaw Capital's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $389K.
- Henshaw Capital fully exited Clarcor in Q1 2017, selling an estimated $1.39M.
- Henshaw Capital's ten largest holdings make up 32% of its $914M portfolio in Q1 2017.
- Henshaw Capital opened 16 new positions and closed 12 in Q1 2017.
- Henshaw Capital's portfolio value rose 8% quarter-over-quarter to $914M.
Based on Henshaw Capital's 13F filing for Q1 2017, filed 28 May 2026.